Publication:
Amino Acid Transport Defects in Human Inherited Metabolic Disorders

dc.contributor.authorYahyaoui, Raquel
dc.contributor.authorPérez-Frías, Javier
dc.contributor.authoraffiliation[Yahyaoui,R] Laboratory of Metabolic Disorders and Newborn Screening Center of Eastern Andalusia, Málaga Regional University Hospital, Málaga, Spain. [Yahyaoui,R] Grupo Endocrinología y Nutrición, Diabetes y Obesidad, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Pérez-Frías,J] Grupo Multidisciplinar de Investigación Pediátrica, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Pérez-Frías,J] Departamento de Farmacología y Pediatría, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
dc.date.accessioned2024-02-10T20:02:41Z
dc.date.available2024-02-10T20:02:41Z
dc.date.issued2019-12-23
dc.description.abstractAmino acid transporters play very important roles in nutrient uptake, neurotransmitter recycling, protein synthesis, gene expression, cell redox balance, cell signaling, and regulation of cell volume. With regard to transporters that are closely connected to metabolism, amino acid transporter-associated diseases are linked to metabolic disorders, particularly when they involve different organs, cell types, or cell compartments. To date, 65 different human solute carrier (SLC) families and more than 400 transporter genes have been identified, including 11 that are known to include amino acid transporters. This review intends to summarize and update all the conditions in which a strong association has been found between an amino acid transporter and an inherited metabolic disorder. Many of these inherited disorders have been identified in recent years. In this work, the physiological functions of amino acid transporters will be described by the inherited diseases that arise from transporter impairment. The pathogenesis, clinical phenotype, laboratory findings, diagnosis, genetics, and treatment of these disorders are also briefly described. Appropriate clinical and diagnostic characterization of the underlying molecular defect may give patients the opportunity to avail themselves of appropriate therapeutic options in the future.
dc.identifier.doi10.3390/ijms21010119
dc.identifier.e-issn1422-0067es_ES
dc.identifier.journalInternational Journal of Molecular Scienceses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/3627
dc.identifier.pubmedID31878022es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17944
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/21/1/119/htmes
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSLC
dc.subjectSolute carriers
dc.subjectMembrane transport
dc.subjectInborn errors of metabolism
dc.subjectAmino acid transporter
dc.subjectSymporter
dc.subjectInherited metabolic disorders
dc.subjectProteínas transportadoras de solutos
dc.subjectErrores innatos del metabolismo
dc.subjectSistemas de transporte de aminoácidos
dc.subjectSimportadores
dc.subjectEncefalopatías metabólicas innatas
dc.subject.meshBiological Transport, Active
dc.subject.meshHumans
dc.subject.meshSignal Transduction
dc.subject.meshAmino Acid Transport Systems
dc.subject.meshAmino Acids
dc.subject.meshMetabolism, Inborn Errors
dc.subject.meshBrain Diseases, Metabolic, Inborn
dc.subject.meshGenes
dc.subject.meshPhenotype
dc.titleAmino Acid Transport Defects in Human Inherited Metabolic Disorders
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files